Delivery Order SPE2DB22D3102-SPE2DB24FL0SC
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,961.80 firm fixed price delivery order is for the supply of 100 units of the medication VYVANSE 10 MG CAPSULE. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order worth $1,965.56 for the supply of VYVANSE 30 MG CAPSULE 100S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,724.00 firm fixed price delivery order is for VYVANSE 50 MG CAPSULE 100S, with a completion date of February 6, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $23,512.73 firm fixed price delivery order is for the supply of VYVANSE CAPS 50MG, a prescription medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $9,063.85 firm fixed-price delivery order was awarded on May 20, 2024 with a completion date of May 21, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025 with the DLA...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,293.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564135764 - VYVANSE 60 MG CAPSULE 100S. This delivery order contract has a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order for VYVANSE 40 MG CAPSULE 100S valued at $2,488.99. The contract was awarded by the Defense Logistics Agency (DLA) on March 1, 2024, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as the prime contractor providing pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a delivery order valued at $1,724.00, is for the provision of 4564214559 VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 9, 2024. This award is not associated...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VYVANSE 70 MG CAPSULE 100S. The contract, valued at $4,448.45, is a Firm Fixed Price Delivery Order with a completion date of May 1, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will fulfill this order. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract is for the delivery of VYVANSE CAPS 60MG, a pharmaceutical product, with a ceiling value of $11,226.44 and a performance period through April 15, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB24FL0SCDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a delivery order valued at $2,603.07. It was issued by the Defense Logistics Agency (DLA), a defense agency, to provide VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of April 1, 2024. The award is a firm fixed price contract and does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on this award. Additionally, Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 3/29/24 |